151 related articles for article (PubMed ID: 12471874)
1. Imaging of intrathoracic metastases of nonseminomatous germ cell tumors.
Meyer CA; Conces DJ
Chest Surg Clin N Am; 2002 Nov; 12(4):717-38. PubMed ID: 12471874
[TBL] [Abstract][Full Text] [Related]
2. Surgical techniques for testicular nonseminomatous germ cell tumors metastatic to the mediastinum.
Kesler KA
Chest Surg Clin N Am; 2002 Nov; 12(4):749-68. PubMed ID: 12471876
[TBL] [Abstract][Full Text] [Related]
3. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
Spermon JR; De Geus-Oei LF; Kiemeney LA; Witjes JA; Oyen WJ
BJU Int; 2002 Apr; 89(6):549-56. PubMed ID: 11942962
[TBL] [Abstract][Full Text] [Related]
4. Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: analysis of a single-institution experience.
Kesler KA; Wilson JL; Cosgrove JA; Brooks JA; Messiha A; Fineberg NS; Einhorn LH; Brown JW
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):408-15. PubMed ID: 16077406
[TBL] [Abstract][Full Text] [Related]
5. 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
Huddart RA; O'Doherty MJ; Padhani A; Rustin GJ; Mead GM; Joffe JK; Vasey P; Harland SJ; Logue J; Daugaard G; Hain SF; Kirk SJ; MacKewn JE; Stenning SP;
J Clin Oncol; 2007 Jul; 25(21):3090-5. PubMed ID: 17634488
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.
Stephens AW; Gonin R; Hutchins GD; Einhorn LH
J Clin Oncol; 1996 May; 14(5):1637-41. PubMed ID: 8622082
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors.
Albers P; Bender H; Yilmaz H; Schoeneich G; Biersack HJ; Mueller SC
Urology; 1999 Apr; 53(4):808-11. PubMed ID: 10197862
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
Tsatalpas P; Beuthien-Baumann B; Kropp J; Manseck A; Tiepolt C; Hakenberg OW; Burchert W; Franke WG; Wirth MP
Urol Int; 2002; 68(3):157-63. PubMed ID: 11919460
[TBL] [Abstract][Full Text] [Related]
10. PET imaging in the management of tumors of testis and ovary: current thinking and future directions.
Basu S; Rubello D
Minerva Endocrinol; 2008 Sep; 33(3):229-56. PubMed ID: 18846028
[TBL] [Abstract][Full Text] [Related]
11. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
[TBL] [Abstract][Full Text] [Related]
12. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer--a necessary risk?
Harvey ML; Geldart TR; Duell R; Mead GM; Tung K
Ann Oncol; 2002 Feb; 13(2):237-42. PubMed ID: 11886000
[TBL] [Abstract][Full Text] [Related]
13. The future of therapy for nonseminomatous germ cell tumors.
Donadio AC; Bosl GJ
Chest Surg Clin N Am; 2002 Nov; 12(4):769-89. PubMed ID: 12471877
[TBL] [Abstract][Full Text] [Related]
14. FDG PET for detection and therapy control of metastatic germ cell tumor.
Cremerius U; Effert PJ; Adam G; Sabri O; Zimmy M; Wagenknecht G; Jakse G; Buell U
J Nucl Med; 1998 May; 39(5):815-22. PubMed ID: 9591582
[TBL] [Abstract][Full Text] [Related]
15. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
[TBL] [Abstract][Full Text] [Related]
16. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
[TBL] [Abstract][Full Text] [Related]
17. Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery.
Kesler KA; Brooks JA; Rieger KM; Fineberg NS; Einhorn LH; Brown JW
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):913-23. PubMed ID: 12698156
[TBL] [Abstract][Full Text] [Related]
18. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.
Oechsle K; Hartmann M; Brenner W; Venz S; Weissbach L; Franzius C; Kliesch S; Mueller S; Krege S; Heicappell R; Bares R; Bokemeyer C; de Wit M;
J Clin Oncol; 2008 Dec; 26(36):5930-5. PubMed ID: 19018083
[TBL] [Abstract][Full Text] [Related]
19. [Radiologic staging after surgical, chemical, and radiation treatment of non-seminomatous tumors of the testis].
Gualdi GF; Petta S; Liberti M; Casciani E; Polettini E; Perugia G; Stano C
Arch Ital Urol Androl; 1997 Feb; 69 Suppl 1():9-14. PubMed ID: 9181931
[TBL] [Abstract][Full Text] [Related]
20. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
Sheinfeld J
Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
